Nadia Nabulsi
8PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 30, 2025
Economic impact of using cariprazine as the first versus subsequent adjunctive therapy for Medicaid beneficiaries with major depressive disorder.Prakash S Masand, Anita H Clayton, Mousam Parikh
|Sep 04, 2025
Real-World Disability Outcomes Among Patients Treated with Cariprazine vs Other Atypical Antipsychotics as Adjunctive Treatment for Major Depressive Disorder.Prakash S Masand, Mousam Parikh, Jamie T Ta
|May 30, 2025
Real-world effectiveness of cariprazine in major depressive disorder and bipolar I disorder in the United States.Roger S McIntyre, Mousam Parikh, Jamie Ta
|Feb 19, 2025
The real-world impact of cariprazine on short- and long-term disability outcomes among commercially insured patients in the United States.Prakash S Masand, Mousam Parikh, Jamie Ta
|Jan 22, 2025
Healthcare resource utilization and costs of using cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder.Prakash S Masand, Anita H Clayton, Mousam Parikh
|Nov 09, 2023
Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies.Nadia A Nabulsi, Lisa K Sharp, Karen I Sweiss
Pageof 2
Frequent Collaborators
4 joint publications
François Laliberté
2 joint publications
Guillaume Germain
2 joint publications
Anita H Clayton
2 joint publications
Prakash S Masand
1 joint publications
Susannah Ripley
1 joint publications
Ben S Gerber
1 joint publications
Itika Gupta
1 joint publications
Barbara Di Eugenio
1 joint publications
Brian Ziebart
1 joint publications
Lisa K Sharp
